Postoperative Epidural Analgesia in Spine Fusion Surgery
NCT ID: NCT01838707
Last Updated: 2013-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
60 participants
INTERVENTIONAL
2007-12-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analgesic Efficacy of Paravertebral Morphine
NCT03379987
A Prospective Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia
NCT01828840
Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery
NCT06007378
Perioperative Pain Management for Lumbar Spine Surgery
NCT06662318
Rectus Sheath Block: Postoperative Analgesia and Proinflammatory Cytokines
NCT03074097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bupivacaine
0.125% Bupivacaine HCL @ 4-5 ml/h
0.125% Bupivacaine HCL @ 4-5 ml/h
Bupivacaine, Morphine
0.125% Bupivacaine HCL , Morphine sulphate 3 mg @ 3-5 ml/h
0.125% Bupivacaine HCL , Morphine sulphate @ 3 mg 3-5 ml/h
Bupivacaine, Fentanyl
0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h
0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.125% Bupivacaine HCL @ 4-5 ml/h
0.125% Bupivacaine HCL , Morphine sulphate @ 3 mg 3-5 ml/h
0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omnia Askar
assistant lecturer of anesthesia and ICU, Assiut University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omnia A Abd El Raof, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1976
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.